RET and neoplasm: Vitamin C has antitumoural activity by altering redox homeostasis. It can also induce ROS production and depletion of antioxidant defences in PTC cells with BRAFV600 mutation. However, this was not true for the cells characterized by RET/PTC rearrangements, indicating the idea that this compound exerts a selective effect in tumour cells with specific mutations